Evidence map›Paper›PMID 31443568›Full record

ArticleInternational journal of molecular sciences2019

Neuroprotective and Anti-Inflammatory Effects of a Hydrophilic Saffron Extract in a Model of Glaucoma.

Jose A Fernández-Albarral, Ana I Ramírez, Rosa de Hoz, Nerea López-Villarín, Elena Salobrar-García, Inés López-Cuenca, Ester Licastro, Antonio M Inarejos-García, Paula Almodóvar, Maria D Pinazo-Durán and 2 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Plant-Based Care and Therapy in Ophthalmology.Antioxidants (Basel, Switzerland) · 2025
    Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jose A Fernández-AlbarralInstituto de Investigaciones Oftalmológicas Ramón Castroviejo, UCM, 28040 Madrid, Spain.ORCID 0000-0003-0399-7996
Ana I RamírezInstituto de Investigaciones Oftalmológicas Ramón Castroviejo, UCM, 28040 Madrid, Spain.
Rosa de HozInstituto de Investigaciones Oftalmológicas Ramón Castroviejo, UCM, 28040 Madrid, Spain.
Nerea López-VillarínInstituto de Investigaciones Oftalmológicas Ramón Castroviejo, UCM, 28040 Madrid, Spain.
Elena Salobrar-GarcíaInstituto de Investigaciones Oftalmológicas Ramón Castroviejo, UCM, 28040 Madrid, Spain.ORCID 0000-0001-5939-5551
Inés López-CuencaInstituto de Investigaciones Oftalmológicas Ramón Castroviejo, UCM, 28040 Madrid, Spain.
Ester LicastroInstituto de Investigaciones Oftalmológicas Ramón Castroviejo, UCM, 28040 Madrid, Spain.
Antonio M Inarejos-GarcíaPharmactive Biotech Products, SL. Parque Científico de Madrid, Faraday 7, 28049 Madrid, Spain.
Paula AlmodóvarPharmactive Biotech Products, SL. Parque Científico de Madrid, Faraday 7, 28049 Madrid, Spain.
Maria D Pinazo-DuránUnidad de Investigación Oftalmológica Santiago Grisolia, Universidad de Valencia, 46017 Valencia, Spain.
José M RamírezInstituto de Investigaciones Oftalmológicas Ramón Castroviejo, UCM, 28040 Madrid, Spain. ramirezs@med.ucm.es.
Juan J SalazarInstituto de Investigaciones Oftalmológicas Ramón Castroviejo, UCM, 28040 Madrid, Spain. jjsalaza@med.ucm.es.ORCID 0000-0001-5480-5902

Funding

NCI CLINICAL INVESTIGATOR AWARD PROGRAMK08CA001023 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI FOGLIA, ROBERT P · 1985 to 1985
–
Instituto de Salud Carlos III RD16/0008/0005Instituto de Salud Carlos III RD16/0008/0026Ministerio de Ciencia, Innovación y Universidades FPU17/01023Ministerio de Economía y Competitividad SAF-2014-53779-RMinisterio de Educación, Cultura y Deporte FPU13/01910Universidad Complutense de Madrid Articulo 83 118-2017Universidad Complutense de Madrid CT42/18-CT43/18
6 · The paper itself

Abstract

Glaucoma is a neurodegenerative disease characterized by the loss of retinal ganglion cells (RGCs). An increase in the intraocular pressure is the principal risk factor for such loss, but controlling this pressure does not always prevent glaucomatous damage. Activation of immune cells resident in the retina (microglia) may contribute to RGC death. Thus, a substance with anti-inflammatory activity may protect against RGC degeneration. This study investigated the neuroprotective and anti-inflammatory effects of a hydrophilic saffron extract standardized to 3% crocin content in a mouse model of unilateral, laser-induced ocular hypertension (OHT). Treatment with saffron extract decreased microglion numbers and morphological signs of their activation, including soma size and process retraction, both in OHT and in contralateral eyes. Saffron extract treatment also partially reversed OHT-induced down-regulation of P2RY12. In addition, the extract prevented retinal ganglion cell death in OHT eyes. Oral administration of saffron extract was able to decrease the neuroinflammation associated with increased intraocular pressure, preventing retinal ganglion cell death. Our findings indicate that saffron extract may exert a protective effect in glaucomatous pathology.

Indexed as

AnimalsAnti-Inflammatory AgentsBiomarkersCrocusDisease Models, AnimalGlaucomaHydrophobic and Hydrophilic InteractionsIntraocular PressureMiceMicrogliaNeuroprotective AgentsPlant ExtractsRetinaAnti-Inflammatory AgentsBiomarkersNeuroprotective AgentsPlant ExtractsBrn3aexperimental glaucomaganglion cellsIba-1microglianeuroinflammationneuroprotectionP2RY12retinasaffron extract

Identifiers

PMID31443568
PMCPMC6747458

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.